Product Comparison

No selection bias. No ranking bias. No fees.
CoreView sorts products on the key evidence-based characteristics that matter most, according to high-quality research. All relevant products available in North America are included with monographs. The default presentation sorts products based on evidence-based characteristics, published high-quality research, and region of availability.
Tip: To sort by multiple columns, hold the Shift key while clicking each column. Compare Reset
Number of Reports Cross-Linked Molecular Weight Category Injections Compare
SYNVISC 18
Sanofi
Canada, United States
Yes High ≤3
SYNVISC-ONE 1
Sanofi
Canada, United States
Yes High ≤3
DUROLANE 5
Q-Med AB
Canada
Yes High ≤3
EUFLEXXA 3
Bio-Technology General (Israel) Ltd.
Canada, United States
No High ≤3
Gel-One 1
Seikagaku Corporation
United States
Yes High ≤3
Monovisc 0
Anika Therapeutics, Inc.
Canada, United States
Yes Moderate ≤3
Orthovisc 7
Anika Therapeutics, Inc.
Canada, United States
No Moderate ≤3
Hyalgan 22
Fidia Farmaceutici S.p.a.
Canada, United States
No Low >3
SUPARTZ 7
Seikagaku Corporation
United States
No Low >3
GenVisc 850 2
Tedec-Meiji Farma, S.A.
United States
No Low >3
Gel-Syn 1
Institut Biochimique S.A. (IBSA)
United States
No Low ≤3
SUPLASYN 1
Bioniche Teoranta
Canada
No Low ≤3
HYMOVIS 0
Fidia Farmaceutici S.p.a.
United States
No Low ≤3
NeoVisc 0
Aralez Pharmaceuticals Inc.
Canada
No Low ≤3
If we are missing a product, please let us know